Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in advanced NSCLC or CRC
NCT01676714Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Feb 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dovitinib in non-small cell lung cancer (NSCLC), colorectal cancer (CRC), sponsored by University of California, Davis. Started Feb 2013; status: completed.
02
Drugs
dovitinib
03
Conditions
non-small cell lung cancer (NSCLC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01676714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676714.